JP4900983B2 - 膵臓癌の検出方法 - Google Patents

膵臓癌の検出方法 Download PDF

Info

Publication number
JP4900983B2
JP4900983B2 JP2011526157A JP2011526157A JP4900983B2 JP 4900983 B2 JP4900983 B2 JP 4900983B2 JP 2011526157 A JP2011526157 A JP 2011526157A JP 2011526157 A JP2011526157 A JP 2011526157A JP 4900983 B2 JP4900983 B2 JP 4900983B2
Authority
JP
Japan
Prior art keywords
fucose
pancreatic cancer
haptoglobin
lectin
detecting pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011526157A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2011089988A1 (ja
Inventor
夕香 小林
健 草間
麻直 亀井
Original Assignee
株式会社Ｊ−オイルミルズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社Ｊ−オイルミルズ filed Critical 株式会社Ｊ−オイルミルズ
Priority to JP2011526157A priority Critical patent/JP4900983B2/ja
Application granted granted Critical
Publication of JP4900983B2 publication Critical patent/JP4900983B2/ja
Publication of JPWO2011089988A1 publication Critical patent/JPWO2011089988A1/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/375—Assays involving biological materials from specific organisms or of a specific nature from fungi from Basidiomycetes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2011526157A 2010-01-21 2011-01-17 膵臓癌の検出方法 Expired - Fee Related JP4900983B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011526157A JP4900983B2 (ja) 2010-01-21 2011-01-17 膵臓癌の検出方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2010011447 2010-01-21
JP2010011447 2010-01-21
JP2011526157A JP4900983B2 (ja) 2010-01-21 2011-01-17 膵臓癌の検出方法
PCT/JP2011/050621 WO2011089988A1 (ja) 2010-01-21 2011-01-17 膵臓癌の検出方法

Publications (2)

Publication Number Publication Date
JP4900983B2 true JP4900983B2 (ja) 2012-03-21
JPWO2011089988A1 JPWO2011089988A1 (ja) 2013-05-23

Family

ID=44306790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011526157A Expired - Fee Related JP4900983B2 (ja) 2010-01-21 2011-01-17 膵臓癌の検出方法

Country Status (8)

Country Link
US (1) US8481275B2 (ru)
EP (1) EP2498094B1 (ru)
JP (1) JP4900983B2 (ru)
KR (1) KR101298579B1 (ru)
CN (1) CN103348247B (ru)
ES (1) ES2572127T3 (ru)
RU (1) RU2533219C2 (ru)
WO (1) WO2011089988A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022186318A1 (ja) * 2021-03-03 2022-09-09 株式会社先端生命科学研究所 がん検出方法、がん検査方法、及びこれらに用いるキット

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5263979B2 (ja) * 2010-01-21 2013-08-14 株式会社Ｊ−オイルミルズ 大腸癌の判別方法
JP2013083490A (ja) * 2011-10-06 2013-05-09 Kagoshima Univ 消化器癌診断用マーカー、および消化器癌の検査方法
WO2013055799A1 (en) 2011-10-11 2013-04-18 The Board Of Regents Of The University Of Texas System Biomarker for detecting cancer
KR101384211B1 (ko) * 2012-03-19 2014-04-14 서울대학교산학협력단 췌장암 진단용 마커 및 이의 용도
CN104142403B (zh) * 2013-05-10 2017-10-03 中国医学科学院北京协和医院 Chip蛋白在胰腺癌早期诊断以及预后判断中的用途
KR101582416B1 (ko) 2014-06-30 2016-01-06 가톨릭대학교 산학협력단 프로합토글로빈을 이용한 간암 진단방법
CN104678103A (zh) * 2014-08-05 2015-06-03 首都医科大学附属北京佑安医院 检测血清糖蛋白岩藻糖指数的化学发光蛋白芯片、试剂盒及检测方法
US20170336415A1 (en) * 2015-02-27 2017-11-23 J-Oil Mills, Inc. Signal enhancer
JP2019052092A (ja) * 2016-01-14 2019-04-04 株式会社Ｊ−オイルミルズ 合成スギタケレクチンの親和性を向上させる方法
WO2017204295A1 (ja) * 2016-05-27 2017-11-30 和光純薬工業株式会社 消化器癌の判定方法
KR102095018B1 (ko) 2017-08-14 2020-03-30 중앙대학교 산학협력단 렉틴이 결합된 나노입자를 이용한 암 진단 방법
CN111551723A (zh) * 2020-06-01 2020-08-18 深圳格道糖生物技术有限公司 特定凝集素在基于唾液糖蛋白糖链结构鉴别胰腺癌方面的应用及相关产品
WO2022236017A1 (en) * 2021-05-06 2022-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. L-fucose and anti-androgen receptor therapy for treatment of cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009168470A (ja) * 2008-01-10 2009-07-30 Wako Pure Chem Ind Ltd 膵臓癌マーカーおよび膵臓癌の検査方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101675901B1 (ko) * 2008-07-22 2016-11-15 제이-오일 밀스, 인코포레이티드 Ｌ－푸코스 α1→6 특이적 렉틴

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009168470A (ja) * 2008-01-10 2009-07-30 Wako Pure Chem Ind Ltd 膵臓癌マーカーおよび膵臓癌の検査方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022186318A1 (ja) * 2021-03-03 2022-09-09 株式会社先端生命科学研究所 がん検出方法、がん検査方法、及びこれらに用いるキット

Also Published As

Publication number Publication date
US8481275B2 (en) 2013-07-09
RU2013105265A (ru) 2014-08-20
RU2533219C2 (ru) 2014-11-20
US20120244563A1 (en) 2012-09-27
CN103348247B (zh) 2015-08-12
KR101298579B1 (ko) 2013-08-22
ES2572127T3 (es) 2016-05-30
EP2498094A4 (en) 2012-12-05
EP2498094B1 (en) 2016-02-24
CN103348247A (zh) 2013-10-09
EP2498094A1 (en) 2012-09-12
JPWO2011089988A1 (ja) 2013-05-23
WO2011089988A1 (ja) 2011-07-28
KR20120130795A (ko) 2012-12-03

Similar Documents

Publication Publication Date Title
JP4900983B2 (ja) 膵臓癌の検出方法
JP4514163B2 (ja) フコースα１→６特異的レクチン
JP5754767B2 (ja) Ｐｓａの分析方法、及び前記分析方法を用いた前立腺癌と前立腺肥大症との鑑別方法
Janković et al. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns
Jankovic et al. Glycoforms of CA125 antigen as a possible cancer marker
RU2442989C2 (ru) СПОСОБ ОБНАРУЖЕНИЯ САХАРНЫХ ЦЕПЕЙ С GlcNAc, СИНТЕЗИРОВАННЫХ GnT-V
JP5109001B2 (ja) α１，６フコース糖鎖の検出および分別方法
JP5263979B2 (ja) 大腸癌の判別方法
JPWO2017138457A1 (ja) 高リスク前立腺癌の検出方法、バイオマーカー及び診断薬
Kosanović et al. Sialylation and fucosylation of cancer-associated prostate specific antigen
JP2016205827A (ja) 癌を検出する方法
JP5996831B1 (ja) シグナル増強剤
AU2012309417A1 (en) Method for measuring anti-WT1 antibody
KR101863508B1 (ko) 알파-1산 당단백질에 대한 단일항체 agp501 및 rcaⅱ-hrp 접합체를 포함하는 간경변 또는 간암 특이적 진단용 키트 및 이의 용도
US10150961B2 (en) Methods for preparing monoclonal antibodies recognizing glycan binding site as an epitope
WO2015068851A1 (ja) 前立腺癌と前立腺肥大症との識別方法
WO2009132353A2 (en) Differential diagnosis of prostate cancer and benign prostate disease
Hasija Changes in Erythrocyte Membrane Glycoproteins During Oral Cancer
JP2009236656A (ja) 複合型ｎ型糖鎖の検出方法
JPH09127118A (ja) 酵素免疫測定法

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111221

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111226

R150 Certificate of patent or registration of utility model

Ref document number: 4900983

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150113

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150113

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees